Skip to main content
Boditech Med Inc. logo

Boditech Med Inc. — Investor Relations & Filings

Ticker · 206640 ISIN · KR7206640005 KO Manufacturing
Filings indexed 243 across all filing types
Latest filing 2023-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 206640

About Boditech Med Inc.

https://www.boditech.co.kr/

Boditech Med Inc. is a company specializing in the development, manufacturing, and distribution of in-vitro diagnostic (IVD) solutions. The company focuses on key technologies in immunodiagnostics and molecular diagnostics to provide a range of diagnostic instruments and reagents. Its products are engineered to deliver reliable and accessible testing for various healthcare applications, from point-of-care to laboratory settings. The company's mission is to enhance the quality of life by providing advanced and dependable diagnostic tools to healthcare professionals worldwide.

Recent filings

Filing Released Lang Actions
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Boditech Med, Inc. for the period ending June 30, 2023. It contains detailed financial statements, business operations, capital structure, and management discussions, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself, and it contains substantive financial data. H1 2023
2023-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Boditech Med, detailing quarterly financial highlights such as revenue, operating profit, and net income for the second quarter of 2023. It explicitly states that these are preliminary figures provided for investor convenience before the final audit. This fits the definition of an Earnings Release (ER), which focuses on the initial announcement of periodic financial results. Q2 2023
2023-08-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details the share transactions (specifically '장내매도' or 'on-market sales') by an executive (Nam Ki-bong) of the company Boditech Med. This type of filing is a standard regulatory disclosure for insider trading/director dealings.
2023-05-26 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Boditech Med, Inc.' covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial data, business operations, management discussions, and capital structure information, which is characteristic of a formal interim financial report filed with regulatory bodies (Financial Services Commission and Korea Exchange). Q1 2023
2023-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Boditech Med, detailing quarterly financial highlights such as revenue, operating profit, and net income for Q1 2023. It is a standard regulatory disclosure of preliminary financial results, which fits the definition of an Earnings Release (ER). Q1 2023
2023-05-08 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Termination of a Trust Agreement' (신탁계약해지결과보고서) filed by Boditech Med Co., Ltd. with the Financial Supervisory Service. It details the results of a share repurchase trust contract, including the number of shares acquired and the final status of treasury shares after the contract's termination. This falls under the category of 'Transaction in Own Shares' (POS), as it reports the company's activity regarding the acquisition and holding of its own shares through a trust mechanism.
2023-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.